Jianwen Zhou

Jianwen Zhou

Auto-generated profile, based on publicly available information

Jianwen Zhou

Department of Biology, University of Fribourg

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
JZJianwen Zhou
Jianwen Zhou
NRNikoline Lander Rasmussen
Nikoline Lander Rasmussen
HOHallvard Olsvik
Hallvard Olsvik
VAVyacheslav Akimov
Vyacheslav Akimov
ZHZehan Hu
Zehan Hu
JDJoern Dengjel
Joern Dengjel
Limitation of excessive inflammation due to selective degradation of pro-inflammatory proteins is one of the cytoprotective functions attributed to autophagy. In the current study, we highlight that selective autophagy also plays a vital role in promoting the establishment of a robust inflammatory response. Under inflammatory conditions, here TLR3-activation by poly(I:C) treatment, the inflammation repressor TNIP1 (TNFAIP3 interacting protein 1) is phosphorylated by Tank-binding kinase 1 (TBK1) activating an LIR motif that leads to the selective autophagy-dependent degradation of TNIP1, supporting the expression of pro-inflammatory genes and proteins. This selective autophagy efficiently reduces TNIP1 protein levels early (0–4 h) upon poly(I:C) treatment to allow efficient initiation of the inflammatory response. At 6 h, TNIP1 levels are restored due to increased transcription avoiding sustained inflammation. Thus, similarly as in cancer, autophagy may play a dual role in controlling inflammation depending on the exact state and timing of the inflammatory response.

23 February 2021 in Annals of Surgery
Verified
Journal Article
Open access
LRLijuan Ren
Lijuan Ren
XZXiaoming Zhong
Xiaoming Zhong
WLWei Liu
Wei Liu
DXDi Xu
Di Xu
YLYiyan Lei
Yiyan Lei
ZKZunfu Ke
Zunfu Ke
Objective: To investigate the effectiveness of a CTC-based classifier in stratifying stage IB LUAD. Summary of Background Data: Stage IB LUADs have an approximately 70% 5-year survival rate. The clinical application of ACT is controversial due to inconsistent results in a series of trials and few useful guide biomarkers. Thus, there is a pressing need for robust biomarkers to stratify stage IB patients to define which group would most likely benefit from ACT. Methods: Two hundred twelve stage IB LUAD patients were enrolled and were divided into 3 independent cohorts. The aptamer-modified NanoVelcro system was used to enrich the CTCs. Results: A cutoff of 4 CTCs as the optimal prognostic threshold for stage IB LUAD was generated to stratify the patients in a 70-patient cohort into low-risk and high-risk groups. Patients with ≥ 4 CTCs in the training cohort had shorter progression-free survival (P < 0.0001) and overall survival (P < 0.0001) than patients with 4 CTCs can define a high-risk subgroup, providing a new strategy to make optimal clinical decisions for stage IB LUAD.

13 July 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
PKPanagiota Kolitsida
Panagiota Kolitsida
VNVladimir Nolic
Vladimir Nolic
JZJianwen Zhou
Jianwen Zhou
MSMichael Stumpe
Michael Stumpe
NNNatalie Niemi
Natalie Niemi
HAHagai Abeliovich
Hagai Abeliovich
The mitophagic degradation of mitochondrial matrix proteins inSaccharomyces cerevisiaewas previously shown to be selective, reflecting a pre-engulfment sorting step within the mitochondrial network. This selectivity is regulated through phosphorylation of mitochondrial matrix proteins by the matrix kinases Pkp1 and Pkp2, which in turn appear to be regulated by the phosphatase Aup1/Ptc6. However, these same proteins also regulate the phosphorylation status and catalytic activity of the yeast pyruvate dehydrogenase complex, which is critical for mitochondrial metabolism. To understand the relationship between these two functions, we evaluated the role of the pyruvate dehydrogenase complex in mitophagic selectivity. Surprisingly, we identified a novel function of the complex in regulating mitophagic selectivity, which is independent of its enzymatic activity. Our data support a model in which the pyruvate dehydrogenase complex directly regulates the activity of its associated kinases and phosphatases. This regulatory interaction then determines the phosphorylation state of mitochondrial matrix proteins and their mitophagic fates.

9 March 2023 in Autophagy
Verified
Journal Article
Closed access
NRNikoline Lander Rasmussen
Nikoline Lander Rasmussen
JZJianwen Zhou
Jianwen Zhou
HOHallvard Olsvik
Hallvard Olsvik
SKStephanie Kaeser-Pebernard
Stephanie Kaeser-Pebernard
TLTrond Lamark
Trond Lamark
TJTerje Johansen
Terje Johansen
The inflammatory repressor TNIP1/ABIN-1 is important for keeping in check inflammatory and cell-death pathways to avoid potentially dangerous sustained activation of these pathways. We have now found that TNIP1 is rapidly degraded by selective macroautophagy/autophagy early (0-4 h) after activation of TLR3 by poly(I:C)-treatment to allow expression of pro-inflammatory genes and proteins. A few hours later (6 h), TNIP1 levels rise again to counteract sustained inflammatory signalling. TBK1-mediated phosphorylation of a TNIP1 LIR motif regulates selective autophagy of TNIP1 by stimulating interaction with Atg8-family proteins. This is a novel level of regulation of TNIP1, whose protein level is crucial for controlling inflammatory signalling.

30 April 2026 in Science
Verified
Journal Article
Closed access
LALukas M. Altenburger
Lukas M. Altenburger
DCDaniela Claudino Carvoeiro
Daniela Claudino Carvoeiro
PDPhilippe Dehio
Philippe Dehio
JZJianwen Zhou
Jianwen Zhou
CLChiara Laura
Chiara Laura
JSJens Stein
Jens Stein
The generation of effector CD8 + T cells (T EFF ) requires activation of naïve CCR7 + T cells (T N ) by dendritic cells (DCs) in lymphoid tissue. How T N -DC interaction duration and signal integration are controlled remains unclear. In this study, we show that lymphoid stroma–secreted CCR7 ligands limit interaction duration by progressively inducing CD8 + T cell release from DCs. At late interaction stages, CCR7 ligands relocalize the F-actin regulator DOCK2 away from the DC interface, permitting T cell detachment, proliferation onset, and acquisition of cytotoxicity. Disruption of CCR7 signaling causes prolonged T cell–DC contacts and produces dysfunctional T EFF with elevated inhibitory receptors, reduced antimicrobial activity, and impaired recall responses. Stromal chemokines therefore act as critical regulators of T cell priming by DCs, preserving CD8 + effector function during acute and memory phases.

5 November 2026 in Cancer Discovery
Verified
Journal Article
Open access
MSMagdalena K. Sznurkowska
Magdalena K. Sznurkowska
FCFrancesc Castro-Giner
Francesc Castro-Giner
IDIrene D’ANna
Irene D’ANna
IKIlona Krol
Ilona Krol
YZYongzhan Zhang
Yongzhan Zhang
NANicola Aceto
Nicola Aceto
Breast cancer progression to visceral organs such as the lung and liver is associated with poor prognosis. However, these organs have diverse cellular microenvironments that may differentially influence cancer cell behavior. In this study, we show that breast cancer metastases differ in their capacity for secondary seeding: the liver fosters metastasis-promoting properties and boosts secondary spread, whereas the lung restricts these processes, favoring local growth. Using patient data and rapid autopsy tissues, mouse models with barcode-mediated tracing, niche-labeling technology, and single-cell analysis of tumor cells and their direct microenvironment, we dissect the cellular and molecular microenvironmental factors underlying this differential behavior. Mechanistically, we identify BMP2-producing endothelial cells as critical players within the liver metastatic niche, enhancing metastasis-to-metastasis dissemination. Targeting the BMP2 signaling axis suppresses the secondary spread of liver-derived breast cancer lesions. Altogether, we reveal site-specific behavior of lung and liver metastases in breast cancer, highlighting microenvironmental mechanisms and therapeutic opportunities for intervention. Significance: This study establishes that metastatic organs differentially regulate subsequent breast cancer dissemination, with the liver promoting and the lung restraining secondary spread. We identify endothelial BMP2 as a liver niche signal that metabolically primes breast cancer cells for further metastasis, revealing a therapeutic target to curb secondary spread.